Pneumonia Therapeutics Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Pneumonia Therapeutics Industry Compare Between 2025 And 2029?

The pneumonia therapeutics market has experienced substantial expansion recently. Projections indicate its value will increase from $10.35 billion in 2024 to $11.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. This historical growth is attributable to a rise in the prevalence of drug-resistant strains, heightened awareness of pneumonia prevention, an expanding elderly and immunocompromised demographic, the implementation of broader vaccination programs, and enhancements in healthcare infrastructure.

The pneumonia therapeutics market size is projected to experience swift expansion in the coming years, anticipated to reach $17.11 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period can be attributed to several factors, including the increasing emergence of antibiotic-resistant strains, the rising prevalence of pneumonia among aging populations, the expansion of telemedicine for early diagnosis, escalating healthcare expenditures in emerging markets, increased funding for infectious disease research, and enhanced awareness campaigns. Major trends anticipated in this period involve the development of monoclonal antibodies, the adoption of inhalable antibiotics, innovation in mRNA-based vaccines, AI-driven diagnostic tools, the implementation of host-targeted therapies, novel immunomodulators, and advancements in rapid point-of-care diagnostic platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21258&type=smp

What Are The Drivers Pushing New Developments In The Pneumonia Therapeutics Market?

The expanding occurrence of pneumonia is anticipated to propel the expansion of the pneumonia therapeutics market in the future. Pneumonia is defined as a pulmonary infection characterized by inflammation of the air sacs, frequently leading to symptoms like coughing, elevated temperature, and labored respiration. The surge in pneumonia incidents stems from various elements including an aging demographic, atmospheric contamination, tobacco use, compromised immune defenses, resistance to antimicrobials, and the dissemination of respiratory illnesses such as COVID-19 or influenza. Therapeutics for pneumonia are instrumental in combating the underlying agents of the infection, be it bacteria, viruses, or fungi, through specific medications, simultaneously aiding recuperation via oxygen support, anti-inflammatory agents, and symptom alleviation. To illustrate, in January 2023, data from the National Center for Biotechnology Information, a US-based government agency, indicated that pneumonia impacts approximately 120 million individuals worldwide each year, resulting in about 1.3 million fatalities. A significant portion, nearly 80%, of pneumonia-related deaths in children happen among those under 2 years old in developing countries. Consequently, the expanding occurrence of pneumonia is propelling the growth of the pneumonia therapeutics market.

How Is The Pneumonia Therapeutics Market Classified Into Different Segments?

The pneumonia therapeuticsmarket covered in this report is segmented –

1) By Product: Drugs; Vaccine; Oxygen Therapy

2) By Infection: Hospital-Acquired Pneumonia (HAP); Community-Acquired Pneumonia (CAP); Ventilator-Associated Pneumonia (VAP)

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By End Use: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Drugs: Antibiotics; Antiviral Drugs; Antifungal Drugs; Corticosteroids; Other Drugs

2) By Vaccine: Pneumococcal Vaccines; Haemophilus Influenzae Type B (Hib) Vaccines; Influenza Vaccines; Other Vaccines

3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC); Non-Invasive Ventilation (NIV); Mechanical Ventilation; Other Oxygen Therapies

What Are The Major Trends Driving The Growth Of The Pneumonia Therapeutics Market?

Major companies in the pneumonia therapeutics market are concentrating on creating novel drug formulations and treatment approaches, such as antibiotic drugs, to address antibiotic resistance and enhance patient outcomes. An antibiotic drug is a medication specifically designed to treat bacterial infections. For example, in June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, partnered with Cipla Limited, an India-based pharmaceutical company, to introduce cefepime-enmetazobactam. This antibiotic combination is utilized for managing complex infections, including UTIs and pneumonia, particularly those resistant to other medications. It aids in combating bacterial resistance, providing effective treatment while reducing the reliance on stronger antibiotics.

Which Industry Leaders Are Driving Innovation Across The Pneumonia Therapeutics Market?

Major companies operating in the pneumonia therapeutics market are Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc., Tergene Biotech Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pneumonia-therapeutics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Pneumonia Therapeutics Market?

North America was the largest region in the pneumonia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumonia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pneumonia Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21258&type=smp

Browse Through More Reports Similar to the Global Pneumonia Therapeutics Market 2025, By The Business Research Company

Anti Asthmatics And Copd Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-global-market-report

Asthma Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795